NORWOOD, Mass.--(BUSINESS WIRE)--Aspect Medical Systems, Inc. (Nasdaq: ASPM) and Boston Scientific Corporation (NYSE: BSX) today announced a share repurchase plan and an agreement to conclude their alliance for the development of new brain monitoring products aimed at assisting clinicians in the diagnosis and treatment of depression, Alzheimer’s disease and other neurological conditions.
